MarketPulse

Interventional Urology

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Coloplast A/S

Coloplast Reports 6% Growth but Takes $400M Hit on Kerecis Wound Care Bet

Coloplast reports 6% H1 growth but takes 3.0B DKK Kerecis writedown, revising full-year guidance to 5-6% amid wound care challenges.
CLPBYorganic growthchronic care
GlobeNewswire Inc.GlobeNewswire Inc.··Coloplast A/S

Coloplast Faces Headwinds as Medicare Pressures Kerecis, Impairs DKK 3B Goodwill

Coloplast posts 6% organic revenue growth in H1 2025/26 but takes DKK 3B Kerecis impairment due to Medicare reimbursement challenges, revising full-year guidance.
CLPBYorganic growthMedicare reimbursement